The head office was relocated today on September 28 (Monday) due to business expansion. The relocation destination is inside Hotel New Otani Garden Court, 4-1 Kioicho, Chiyoda-ku, Tokyo. In the future, we will provide more and more people with the primary cancer screening test. In order to deliver “N-NOSE”, we will strengthen the organizational structure and promote smooth operation.
TOKYO, JAPAN – March 6, 2026 – HIROTSU Bio Science Inc. announced the establishment of a new U.S. subsidiary, Hirotsu Global Inc., effectively c . . .
2026.03.06FOR IMMEDIATE RELEASE HIROTSU Bio Science Announces Referral of Former Employee to Prosecutors for Violation of the Unfair Competition Preven . . .
2026.02.05A novel, non-invasive approach to detecting micro-distant metastasis in highly lethal pancreatic cancer. TOKYO, JAPAN – January 5, 2026 – HIR . . .
2026.01.05